This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignee: Ecole Polytechnique Federale De Lausanne. Active years: 2015-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2026
Title: Stéphane Bigler: Innovator in Ocular Drainage Systems
Introduction
Stéphane Bigler is a notable inventor based in Leysin, Switzerland. He has made significant contributions to the field of ocular health, particularly in the treatment of elevated intraocular pressures, such as those caused by glaucoma. With a total of 5 patents, his work focuses on innovative solutions that enhance patient care.
Latest Patents
Stéphane Bigler's latest patents include an advanced ocular drainage system designed to treat diseases that produce elevated intraocular pressures. This system features an implantable device and an external control unit. The implantable device is equipped with a non-invasively adjustable valve that includes at least one deformable tube and a disk rotatably mounted within a housing. By rotating the disk using the external control unit, the disk applies a selected amount of compression to the deformable tube. This mechanism adjusts the fluidic resistance of the tube, thereby regulating intraocular pressure effectively.
Career Highlights
Throughout his career, Stéphane Bigler has worked with prestigious institutions, including the École Polytechnique Fédérale de Lausanne. His experience in these environments has allowed him to develop and refine his innovative ideas in ocular treatment.
Collaborations
Stéphane has collaborated with notable professionals in his field, including Nikolaos Stergiopulos. These partnerships have contributed to the advancement of his research and inventions.
Conclusion
Stéphane Bigler is a prominent figure in the field of ocular health, with a focus on innovative solutions for treating elevated intraocular pressures. His contributions through patents and collaborations highlight his commitment to improving patient outcomes in ophthalmology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
